Atlas Trials

Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients

Clinical trial NCT02891538 · COMPLETED

Trial details

NCT number
NCT02891538
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Colon Cancer
Start date
2017-01-31
Primary completion
2024-06-27
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.